{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "84126-356",
      "generic_name": "Acetaminophen, Dextromethorphan HBr",
      "labeler_name": "The Procter & Gamble Manufacturing Company",
      "brand_name": "Vicks DayQuil INTENSE FLU",
      "brand_name_suffix": "INTENSE FLU",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "1000 mg/30mL"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "30 mg/30mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "84126-356-08",
          "description": "236 mL in 1 BOTTLE, PLASTIC (84126-356-08)",
          "marketing_start_date": "20250707",
          "sample": false
        },
        {
          "package_ndc": "84126-356-12",
          "description": "354 mL in 1 BOTTLE, PLASTIC (84126-356-12)",
          "marketing_start_date": "20250701",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {},
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "LIQUID",
      "spl_id": "5d1ae9e9-0ab8-3229-e063-6294a90aaf44",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250701",
      "product_id": "84126-356_5d1ae9e9-0ab8-3229-e063-6294a90aaf44",
      "application_number": "M012",
      "brand_name_base": "Vicks DayQuil",
      "pharm_class": [
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}